{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T10:46:34Z","timestamp":1768733194116,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ejmech.2019.06.025","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T23:22:10Z","timestamp":1560381730000},"page":"182-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Synthesis and biological evaluation of (1,2,4)triazole[4,3-a]pyridine derivatives as potential therapeutic agents for concanavalin A-induced hepatitis"],"prefix":"10.1016","volume":"179","author":[{"given":"Yaojie","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanfang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinghong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9297-6665","authenticated-orcid":false,"given":"Luoting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6917","key":"10.1016\/j.ejmech.2019.06.025_bib1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"issue":"9573","key":"10.1016\/j.ejmech.2019.06.025_bib2","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","article-title":"Inflammatory bowel disease: cause and immunobiology","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"issue":"7152","key":"10.1016\/j.ejmech.2019.06.025_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.06.025_bib4","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"21","key":"10.1016\/j.ejmech.2019.06.025_bib5","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.3748\/wjg.14.3292","article-title":"Historical reflections on autoimmune hepatitis","volume":"14","author":"Mackay","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2019.06.025_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaut.2015.10.006","article-title":"The clinical phenotypes of autoimmune hepatitis: a comprehensive review","volume":"66","author":"Wang","year":"2016","journal-title":"J.\u00a0Autoimmun."},{"issue":"8","key":"10.1016\/j.ejmech.2019.06.025_bib7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2036.2010.04241.x","article-title":"Review article: the modern management of autoimmune hepatitis","volume":"31","author":"Yeoman","year":"2010","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2019.06.025_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2016.07.005","article-title":"Cutting edge issues in autoimmune hepatitis","volume":"75","author":"Liberal","year":"2016","journal-title":"J.\u00a0Autoimmun."},{"issue":"3","key":"10.1016\/j.ejmech.2019.06.025_bib9","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1159\/000489074","article-title":"Comparison of concanavalin a-induced murine autoimmune hepatitis models","volume":"46","author":"Ye","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"7","key":"10.1016\/j.ejmech.2019.06.025_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrc1910","article-title":"The role of nitric oxide in tumour progression","volume":"6","author":"Fukumura","year":"2006","journal-title":"Nat. Rev. Canc."},{"issue":"1","key":"10.1016\/j.ejmech.2019.06.025_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2008.03.024","article-title":"Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer","volume":"268","author":"Hofseth","year":"2008","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2019.06.025_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nm0197-30","article-title":"Nitric oxide and inflammation: the answer is blowing in the wind","volume":"3","author":"Lundberg","year":"1997","journal-title":"Nat. Med."},{"issue":"5789","key":"10.1016\/j.ejmech.2019.06.025_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.ejmech.2019.06.025_bib14","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","article-title":"Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide","volume":"84","author":"Ignarro","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.ejmech.2019.06.025_bib15","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.4049\/jimmunol.1102111","article-title":"Disruption of nitric oxide signaling by Helicobacter pylori results in enhanced inflammation by inhibition of heme oxygenase-1","volume":"187","author":"Gobert","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2019.06.025_bib16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.redox.2015.08.013","article-title":"Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics","volume":"6","author":"Bonavida","year":"2015","journal-title":"Redox Biol"},{"issue":"3","key":"10.1016\/j.ejmech.2019.06.025_bib17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1189\/jlb.4A0314-139R","article-title":"Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease","volume":"97","author":"Crook","year":"2015","journal-title":"J.\u00a0Leukoc. Biol."},{"issue":"13","key":"10.1016\/j.ejmech.2019.06.025_bib18","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1096\/fj.00.011rev","article-title":"Nitrosation and oxidation in the regulation of gene expression","volume":"14","author":"Marshall","year":"2000","journal-title":"FASEB J."},{"issue":"23","key":"10.1016\/j.ejmech.2019.06.025_bib19","doi-asserted-by":"crossref","first-page":"14214","DOI":"10.1074\/jbc.270.23.14214","article-title":"Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B","volume":"270","author":"Peng","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2019.06.025_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.smim.2015.05.004","article-title":"Gaseous mediators in resolution of inflammation","volume":"27","author":"Wallace","year":"2015","journal-title":"Semin. Immunol."},{"issue":"4","key":"10.1016\/j.ejmech.2019.06.025_bib21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.molmed.2018.02.002","article-title":"Nitric oxide signaling in T cell-mediated immunity","volume":"24","author":"Garcia-Ortiz","year":"2018","journal-title":"Trends Mol. Med."},{"issue":"16","key":"10.1016\/j.ejmech.2019.06.025_bib22","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1016\/j.bmcl.2006.05.056","article-title":"Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical development","volume":"16","author":"McClure","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"6","key":"10.1016\/j.ejmech.2019.06.025_bib23","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.ejmech.2007.07.010","article-title":"CoMFA and docking studies on triazolopyridine oxazole derivatives as p38 MAP kinase inhibitors","volume":"43","author":"Nayana","year":"2008","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2019.06.025_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bmcl.2009.11.114","article-title":"Continued exploration of the triazolopyridine scaffold as a platform for p38 MAP kinase inhibition","volume":"20","author":"Jerome","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"8","key":"10.1016\/j.ejmech.2019.06.025_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/bdd.520","volume":"27","author":"Kalgutkar","year":"2006","journal-title":"Biopharm Drug Dispos."},{"issue":"16","key":"10.1016\/j.ejmech.2019.06.025_bib26","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1016\/j.bmc.2016.05.057","article-title":"Synthesis and biological evaluation of new [1,2,4]triazolo[4,3-a]pyridine derivatives as potential c-Met inhibitors","volume":"24","author":"Zhao","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.025_bib27","unstructured":"Lu, T.; Alexander, R.; Connors, R. W.; Cummings, M. D.; Galemmo, R. A.; Hufnagel, H. R.; Johnson, D. L.; Khalil, E.; Leonard, K. A.; Markotan, T. P., Triazolopyridazines as Kinase Modulators. Google Patents: 2011."},{"issue":"1","key":"10.1016\/j.ejmech.2019.06.025_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/jm0493156","article-title":"(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)- yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes","volume":"48","author":"Kim","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2019.06.025_bib29","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.7150\/ijbs.27459","article-title":"SAK-HV promotes RAW264.7 cells migration mediated by MCP-1 via JNK and NF-kappaB pathways","volume":"14","author":"Chen","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.ejmech.2019.06.025_bib30","doi-asserted-by":"crossref","first-page":"E1213","DOI":"10.1152\/ajpendo.00480.2012","article-title":"Ceramide 1-phosphate induces macrophage chemoattractant protein-1 release: involvement in ceramide 1-phosphate-stimulated cell migration","volume":"304","author":"Arana","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.ejmech.2019.06.025_bib31","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm1284","article-title":"Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis","volume":"11","author":"Camps","year":"2005","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.ejmech.2019.06.025_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bbrc.2009.06.060","article-title":"Phosphoinositide 3-kinase gamma inhibitor ameliorates concanavalin A-induced hepatic injury in mice","volume":"386","author":"Wang","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2019.06.025_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejmech.2016.02.021","article-title":"Discovery of novel sesquistilbene indanone analogues as potent anti-inflammatory agents","volume":"113","author":"Tang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.025_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-pathol-020117-043534","article-title":"Cellular and molecular mechanisms of autoimmune hepatitis","volume":"13","author":"Webb","year":"2018","journal-title":"Annu. Rev. Pathol."},{"issue":"6","key":"10.1016\/j.ejmech.2019.06.025_bib35","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"American association for the study of liver, D., diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ejmech.2019.06.025_bib36","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","author":"European Association for the Study of the L","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ejmech.2019.06.025_bib37","series-title":"Preparation of Triazolopyridine Derivatives as Cannabinoid Receptor 1 Antagonists","author":"Sun","year":"2006"},{"key":"10.1016\/j.ejmech.2019.06.025_bib38","series-title":"Preparation of [1,2,4]triazolo[4,3-A]pyridine Derivatives and Analogous as Sodium Channel Modulators","author":"Corkey","year":"2011"},{"issue":"1","key":"10.1016\/j.ejmech.2019.06.025_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1039\/c0md00009d","article-title":"Synthesis and biological activity of new pyridone diaryl ether non-nucleoside inhibitors of HIV-1 reverse transcriptase","volume":"1","author":"Kennedy-Smith","year":"2010","journal-title":"Medchemcomm"},{"issue":"8","key":"10.1016\/j.ejmech.2019.06.025_bib40","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1021\/acsmedchemlett.6b00168","article-title":"Optimization of a fragment-based screening hit toward potent DOT1L inhibitors interacting in an induced binding pocket","volume":"7","author":"Scheufler","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.06.025_bib41","series-title":"Preparation of Quinazoline Derivatives as PI3 Kinase Inhibitors","author":"Adams","year":"2008"},{"issue":"4","key":"10.1016\/j.ejmech.2019.06.025_bib42","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1159\/000373971","article-title":"Emodin protects against concanavalin A-induced hepatitis in mice through inhibiting activation of the p38 MAPK-NF-kappaB signaling pathway","volume":"35","author":"Xue","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.ejmech.2019.06.025_bib43","doi-asserted-by":"crossref","first-page":"e2534","DOI":"10.1038\/cddis.2016.452","article-title":"Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis","volume":"8","author":"Ye","year":"2017","journal-title":"Cell Death Dis."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419305501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419305501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:57:13Z","timestamp":1759327033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419305501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":43,"alternative-id":["S0223523419305501"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.025","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of (1,2,4)triazole[4,3-a]pyridine derivatives as potential therapeutic agents for concanavalin A-induced hepatitis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}